After a Cinderella run to become the most-expensive S&P 500 stock, the chipmaking colossus plunged nearly $400B.
While the Fed is expected to cut once this year, the future is less certain.
Ozempic-led obesity-treatment craze boosting demand for other products.
Fed rates speculation is weakening cryptocurrency market sentiment.
BofA, Citi, Goldman, and JPMorgan must take remedial action on "shortcomings" in wind-down plans, finds regulators.
Recent moves against issuing firms and money managers show some parallels to the regulator's early crypto focus.
But asset allocators are concerned about concentration.
Traders are expecting the ECB to ease monetary policy.
James Bullard says CPI data supports September easing.
Regulator's board voted that the bank’s plan is deficient.
